The linked FDA records identify Ischemaview, Inc. as the applicant for two substantial-equivalence clearances decided in 2026, both reviewed by the Radiology advisory committee. Earlier filings in the same numbered sources name iSchemaView Inc. and iSchemaView, Inc. at the same Golden, Colorado address, with James Rosa as regulatory contact. The records document device identities, regulation numbers, product codes and decision dates; they do not establish corporate relationships, ownership, commercial status or clinical performance beyond what each filing states. [1][2][5][8][9]
Two 2026 clearances
Rapid ICH (v4.0) was cleared as K262301 with a decision date of October 9, 2026, received July 7, 2026, under regulation 21 CFR 892.2080 and product code QAS, device class II. Rapid Platform (R6.7) was cleared as K261368 with a decision date of September 21, 2026, received April 27, 2026, under regulation 21 CFR 892.2050 and product code QIH. Both carry the decision code SESE, described as Substantially Equivalent, Traditional clearance type, and a Summary statement. [1][2]
The K261368 clearance letter lists the trade name Rapid Platform (R6.7), regulation name Medical Image Management And Processing System, regulatory class II, and product codes QIH and LLZ. The letter is addressed to James Rosa as Chief Regulatory and Compliance Officer at 1120 Washington Ave., Suite 200, Golden, Colorado. That address appears in the filing correspondence and is not treated here as a verified headquarters. [5]
What the platform record covers
The K261368 letter describes a software device that runs on a computer or virtual platform, such as VMware, and can perform image viewing, processing and analysis of images, with data and images acquired through DICOM-compliant imaging devices. This describes the documented scope of the cleared platform record, not a product catalogue. [5]
An earlier Rapid filing, K233512 for Rapid (6.0), lists regulation 21 CFR 892.2050 with product codes QIH and LLZ and describes viewing and quantification of tissue changes in digital images captured by CT and MRI, with common services for imaging modules in the base platform. The public documents do not state how R6.7 differs from that version. [9]
Triage device lineage in the filings
Rapid ICH appears in earlier records under the iSchemaView name. K221456 covers Rapid ICH under 21 CFR 892.2080, product code QAS, class II, and states that performance was validated with phantoms and retrospective case data based on expert reader truthing. K193087 covers RAPID ICH under the same regulation and product code and describes a mobile interface for messaging as a difference from the named predicate. [8][10]
These earlier documents are separate filings from the 2026 clearances and are cited only for what they state about the named devices. They do not establish that the 2026 versions share identical performance, labeling or software. [8][10]
How to read the collection counts
The supplied portfolio snapshot, retrieved November 20, 2026, links two 510(k) records, both with decision SESE. The smaller record sample also contains two entries, both SESE, corresponding to K262301 and K261368. These counts describe the supplied filings at that retrieval time and are not measures of total company sales, total portfolio or safety performance. [1][2]
No recall records appear in the supplied sample. Absence of recall entries in this sample does not establish a recall history or its absence beyond the supplied data. [1][2]
